Software

Manentia’s Go-Live with BSI eClinical Solution Confirms the Successful SME Strategy Adopted by the Swiss Software House

Finding the right eClinical provider can be difficult, especially for a young clinical research organization working with remote staff across two countries. Yet this was not the case for Manentia, a full-service CRO employing clinical research assistants (CRAs) in England and Northern Ireland. As their CEO and Consultant Statistician David Fleet explained, “As soon as we came across BSI Life Sciences, we knew we had found the perfect match for our company. In December 2021, we were urgently looking for a CTMS that would help us manage a large clinical trial starting at the beginning of this year. Besides checking all our boxes, BSI’s eClinical solution was pretty much the only one on the market that ensured go-live in as little as four weeks.”

BSI’s expertise in small and medium-sized enterprises also appears to have played a role in Manentia’s choice. “We knew BSI’s customers included several other CROs and start-ups in Europe and the US,” continued Mr. Fleet. “That gave us confidence, as we are an agile business made up of few core employees and independent consultants, with flat hierarchies. I personally wanted to make sure that everyone felt involved in the software onboarding process, especially the CRAs, who would eventually spend the most time working with the eClinical tool.”

Like other SME clients, Manentia opted for the standard BSI CTMS configuration with integrated eTMF based on the DIA TMF reference model. In addition, they had BSI add additional custom templates for monitoring visit reports and follow-up letters. “Being able to plan and manage site monitoring visits from start to finish in a single place is a huge relief and a great shift for our team,” commented Fiona McNulty, Clinical Research Consultant at Manentia. “This will save us time and improve efficiency overall,” she added.

For Community Manager Life Sciences at BSI, Jan Nielsen, Manentia’s go-live is another success worth celebrating. “With Manentia we’re further expanding our SME portfolio in England and Northern Ireland. I’m confident more customers in the UK will follow.” Mr. Nielsen also emphasized the good collaboration with the whole team at Manentia. “I’m happy we not only delivered on our promises, but also developed a strong professional relationship with all software end users on the client’s side.”

About Manentia Founded in 2015, Manentia Ltd is a full-service CRO based in Salisbury, England, with extensive experience in both Pharma and MEDDEV studies. Specialist areas include stem cells, vaccines, diagnostic/biomarkers, hospital registries, ePRO/eCOA, sequential methods and population pharmacokinetics. Their motto, “Better Drugs Through Better Testing,” summarizes their mission to take clinical innovation to marketed products. Through its over seven years in business, Manentia has worked with major sponsors in the UK and internationally, providing strategic consultancy, clinical oversight including monitoring and patient recruitment, and data management and analysis. www.manentia.co.uk

 

Über die BSI Business Systems Integration AG

BSI offers smart eClinical software for CTMS, eTMF and more. BSI makes life science software for people – and has done so for 25+ years. BSI’s software solutions made in Switzerland, Germany, USA and anywhere else clients need them to be, are innovative and user-friendly. They focus resources on staying ahead of the trends and delivering functional, compliant, and affordable eClinical software. In this way, BSI helps its customers continuously optimize and accelerate the clinical development process. And that’s what they love! www.bsi-lifesciences.com

Firmenkontakt und Herausgeber der Meldung:

BSI Business Systems Integration AG
Täfernweg 1
CH5405 Baden
Telefon: +41 (56) 48419-20
Telefax: +41 (56) 48419-30
http://www.bsi-software.com

Ansprechpartner:
Charlotte Malz
Marketing & Communications Manager
Telefon: +41 (41) 76686-33
E-Mail: Charlotte.Malz@bsi-software.com
Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel